An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with … [+7253 chars]
EURO 2020 match …
Arrested…
Almost l…
Leave Comments